CDH2 and cancer: Equally, the cadherin switch—downregulation of CDH1 (E-cadherin) and upregulation of CDH2 (N-cadherin)—is a hallmark of EMT that enhances migratory and invasive behavior across cancer types, including NSCLC (26).